Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Veracyte, Inc. - Common Stock (NQ:VCYT)

35.15 -0.84 (-2.33%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,021,087
Open	35.93
Bid (Size)	35.15 (700)
Ask (Size)	35.19 (200)
Prev. Close	35.99
Today's Range	34.17 - 36.09
52wk Range	22.61 - 50.71
Shares Outstanding	67,473,870
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

February 04, 2026

From Veracyte, Inc.

Via Business Wire

Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate ↗

January 26, 2026

Via Chartmill

Performance

YTD	-17.1%	-17.1%
1 Month	-19.1%	-19.1%
3 Month	-16.9%	-16.9%
6 Month	+14.6%	+14.6%
1 Year	-14.2%	-14.2%

More News

Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability

January 12, 2026

Via MarketMinute

Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results

January 11, 2026

From Veracyte, Inc.

Via Business Wire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 29, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Inc (NASDAQ:VCYT) Emerges as a Top Affordable Growth Stock ↗

December 25, 2025

Via Chartmill

Veracyte Inc (NASDAQ:VCYT): A GARP Stock With Strong Growth and a Reasonable Price ↗

December 02, 2025

Via Chartmill

Veracyte to Participate in Upcoming Investor Conferences

November 06, 2025

From Veracyte, Inc.

Via Business Wire

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗

November 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Veracyte Announces Third Quarter 2025 Financial Results

November 04, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing

November 03, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Inc (NASDAQ:VCYT): An Affordable Growth Candidate in Biotech ↗

October 30, 2025

Via Chartmill

Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025

October 15, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Inc (NASDAQ:VCYT) Presents a Strong Growth and Breakout Opportunity ↗

October 14, 2025

Via Chartmill

Veracyte Inc (NASDAQ:VCYT): An Affordable Growth Candidate in Cancer Diagnostics ↗

October 08, 2025

Via Chartmill

Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer

September 28, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025

September 24, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting

September 09, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 29, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

August 26, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

August 27, 2025

From Veracyte, Inc.

Via Business Wire

Veracyte Inc (NASDAQ:VCYT) Emerges as a Strong Value Pick with Solid Fundamentals and Growth Potential ↗

August 13, 2025

Via Chartmill

Veracyte (VCYT) Q2 Revenue Jumps 14% ↗

August 07, 2025

Via The Motley Fool

Frequently Asked Questions

Is Veracyte, Inc. - Common Stock publicly traded?

Yes, Veracyte, Inc. - Common Stock is publicly traded.

What exchange does Veracyte, Inc. - Common Stock trade on?

Veracyte, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Veracyte, Inc. - Common Stock?

The ticker symbol for Veracyte, Inc. - Common Stock is VCYT on the Nasdaq Stock Market

What is the current price of Veracyte, Inc. - Common Stock?

The current price of Veracyte, Inc. - Common Stock is 35.15

When was Veracyte, Inc. - Common Stock last traded?

The last trade of Veracyte, Inc. - Common Stock was at 02/12/26 04:00 PM ET

What is the market capitalization of Veracyte, Inc. - Common Stock?

The market capitalization of Veracyte, Inc. - Common Stock is 2.37B

How many shares of Veracyte, Inc. - Common Stock are outstanding?

Veracyte, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.